By Dimitri Shelest – In October 2021, the San Leandro Hospital emergency room was locked down when a visitor, upset that COVID-19 restrictions prevented him from visiting a patient, threatened to bring a gun to the California healthcare facility. The incident is emblematic of a troubling trend of more frequent and severe violent episodes at healthcare facilities.
Read More
By Devin Partida – Many companies in the health care sector are making digital transformations by adopting cloud computing technology and other improved IT solutions. With new technologies, the need for enhanced cybersecurity measures grows.
Supporting the adoption of health IT and the promotion of nationwide health information exchange to improve health care, here is what is happening at the ONC, including several events, including the Inferno Office Hours for Health IT Developers, the Spring sessions on the 2022 ONC Annual Meeting & the TEFCA RCE Stakeholder Sessions.
We are seeking out the latest developments around Telemedicine. News from Rhinogram, Lyric Health, OpenLoop, Amwell, Teladoc Health, TytoCare, Reliq Health Technologies, HealthPoint Plus, Let’s Talk Interactive, FCC and more.
Latest announcements made from companies and organizations on hiring include CipherHealth, American Medical Association, Zelis, eHealth Technologies, Curebase, COTA, LexisNexis Risk Solutions, NYeC, UpStream Healthcare, Lumeon, and Clover Health.
With the reporting of 26,000 attendees, HIMSS seems to be getting back on track and moving in the right direction. So what were the reactions? What were the takeaways? Will the exhibitors and attendees return next year? Here is what they told us.
Latest news being reported on payers and the health insurance industry including news from KindHealth, AHIP, Independence Blue Cross, Anthem, CVS Health, UnitedHealth Group, Humana, CareSource, Cigna, Blue Cross Blue Shield Association and more.
RISE National 2022 was held in Nashville this month and professionals of all levels in the Medicare Advantage and ACA market were in attendance. Here are a few thoughts and takeaways.
By Robert E. Winkler MD – COVID-19 vaccines were developed extremely fast, approximately nine months from pandemic emergence to FDA approval in the U.S. This is, by a landslide, a record for one of the fastest development (and approval) of a vaccine, and significantly faster than traditional R&D timelines.